Unigestion Holding SA boosted its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 473.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 178,523 shares of the pharmacy operator’s stock after buying an additional 147,392 shares during the quarter. Unigestion Holding SA’s holdings in Walgreens Boots Alliance were worth $9,874,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. Sageworth Trust Co acquired a new stake in Walgreens Boots Alliance in the 2nd quarter worth $27,000. Quest Capital Management Inc. ADV acquired a new stake in Walgreens Boots Alliance in the 3rd quarter worth $31,000. First Interstate Bank grew its position in Walgreens Boots Alliance by 228.1% in the 2nd quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 422 shares during the last quarter. TRUE Private Wealth Advisors acquired a new stake in Walgreens Boots Alliance in the 2nd quarter worth $38,000. Finally, Golden State Wealth Management LLC acquired a new stake in Walgreens Boots Alliance in the 2nd quarter worth $38,000. Institutional investors and hedge funds own 60.60% of the company’s stock.

In related news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of Walgreens Boots Alliance stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the completion of the transaction, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at approximately $18,064,318.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 15.73% of the company’s stock.

Several analysts have issued reports on WBA shares. Deutsche Bank started coverage on shares of Walgreens Boots Alliance in a research report on Thursday, September 12th. They issued a “sell” rating on the stock. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research report on Friday, August 23rd. Bank of America decreased their price target on shares of Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating on the stock in a research report on Thursday, October 3rd. Cleveland Research reaffirmed a “hold” rating on shares of Walgreens Boots Alliance in a report on Monday, September 9th. Finally, Pivotal Research reduced their price objective on shares of Walgreens Boots Alliance from $60.00 to $55.00 and set a “hold” rating for the company in a report on Wednesday, October 30th. Five equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $61.35.

Shares of NASDAQ:WBA traded up $0.57 during midday trading on Friday, reaching $59.24. 5,449,933 shares of the company’s stock were exchanged, compared to its average volume of 5,855,335. The company’s 50 day simple moving average is $55.01 and its two-hundred day simple moving average is $53.51. The firm has a market capitalization of $54.63 billion, a PE ratio of 9.89, a price-to-earnings-growth ratio of 1.53 and a beta of 0.87. Walgreens Boots Alliance Inc has a 12 month low of $49.03 and a 12 month high of $86.31. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.36 and a current ratio of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Monday, October 28th. The pharmacy operator reported $1.43 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. The company had revenue of $33.95 billion during the quarter, compared to the consensus estimate of $33.88 billion. Walgreens Boots Alliance had a net margin of 2.91% and a return on equity of 21.99%. The firm’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same period last year, the firm earned $1.48 EPS. On average, research analysts anticipate that Walgreens Boots Alliance Inc will post 5.93 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a dividend of $0.458 per share. This represents a $1.83 annualized dividend and a yield of 3.09%. The ex-dividend date of this dividend is Friday, November 15th. Walgreens Boots Alliance’s dividend payout ratio is currently 30.55%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Read More: How does new data get added to a blockchain?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.